Cargando…

Incidence of posterior capsule opacification following phacoemulsification in patients with uveitis

PURPOSE: The purpose of this study was to evaluate the incidence of posterior capsule opacification (PCO) in patients with inactive uveitis who underwent phacoemulsification with acrylic hydrophobic intraocular lens. METHODS: Thus was a retrospective review of 25 consecutive patients (31 eyes) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoughy, Samir S., Jaroudi, Mahmoud O., Tabbara, Khalid F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081085/
https://www.ncbi.nlm.nih.gov/pubmed/34085010
http://dx.doi.org/10.4103/1319-4534.310414
_version_ 1783685563871657984
author Shoughy, Samir S.
Jaroudi, Mahmoud O.
Tabbara, Khalid F.
author_facet Shoughy, Samir S.
Jaroudi, Mahmoud O.
Tabbara, Khalid F.
author_sort Shoughy, Samir S.
collection PubMed
description PURPOSE: The purpose of this study was to evaluate the incidence of posterior capsule opacification (PCO) in patients with inactive uveitis who underwent phacoemulsification with acrylic hydrophobic intraocular lens. METHODS: Thus was a retrospective review of 25 consecutive patients (31 eyes) with uveitis who underwent phacoemulsification. A group of 100 patients (140 eyes) without uveitis served as historical controls. RESULTS: In patients with uveitis, PCO occurred in 11 eyes (35.5%), 6 (19%) of which were visually significant and required treatment with neodymium-doped yttrium aluminum garnet (Nd: YAG) laser. In the control group, PCO developed in 17 (12%) eyes which required treatment with Nd: YAG laser. The incidence of PCO was significantly higher in uveitis patients compared to the control group (P = 0.001), but the incidence of visually significant PCO requiring laser capsulotomy was not statistically significant (P = 0.3). CONCLUSION: The incidence of PCO in patients with uveitis was significantly higher than those without uveitis, but the need for Nd: YAG laser capsulotomy for visually significant PCO was not statistically significant.
format Online
Article
Text
id pubmed-8081085
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80810852021-06-02 Incidence of posterior capsule opacification following phacoemulsification in patients with uveitis Shoughy, Samir S. Jaroudi, Mahmoud O. Tabbara, Khalid F. Saudi J Ophthalmol Original Article PURPOSE: The purpose of this study was to evaluate the incidence of posterior capsule opacification (PCO) in patients with inactive uveitis who underwent phacoemulsification with acrylic hydrophobic intraocular lens. METHODS: Thus was a retrospective review of 25 consecutive patients (31 eyes) with uveitis who underwent phacoemulsification. A group of 100 patients (140 eyes) without uveitis served as historical controls. RESULTS: In patients with uveitis, PCO occurred in 11 eyes (35.5%), 6 (19%) of which were visually significant and required treatment with neodymium-doped yttrium aluminum garnet (Nd: YAG) laser. In the control group, PCO developed in 17 (12%) eyes which required treatment with Nd: YAG laser. The incidence of PCO was significantly higher in uveitis patients compared to the control group (P = 0.001), but the incidence of visually significant PCO requiring laser capsulotomy was not statistically significant (P = 0.3). CONCLUSION: The incidence of PCO in patients with uveitis was significantly higher than those without uveitis, but the need for Nd: YAG laser capsulotomy for visually significant PCO was not statistically significant. Wolters Kluwer - Medknow 2021-02-27 /pmc/articles/PMC8081085/ /pubmed/34085010 http://dx.doi.org/10.4103/1319-4534.310414 Text en Copyright: © 2021 Saudi Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Shoughy, Samir S.
Jaroudi, Mahmoud O.
Tabbara, Khalid F.
Incidence of posterior capsule opacification following phacoemulsification in patients with uveitis
title Incidence of posterior capsule opacification following phacoemulsification in patients with uveitis
title_full Incidence of posterior capsule opacification following phacoemulsification in patients with uveitis
title_fullStr Incidence of posterior capsule opacification following phacoemulsification in patients with uveitis
title_full_unstemmed Incidence of posterior capsule opacification following phacoemulsification in patients with uveitis
title_short Incidence of posterior capsule opacification following phacoemulsification in patients with uveitis
title_sort incidence of posterior capsule opacification following phacoemulsification in patients with uveitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081085/
https://www.ncbi.nlm.nih.gov/pubmed/34085010
http://dx.doi.org/10.4103/1319-4534.310414
work_keys_str_mv AT shoughysamirs incidenceofposteriorcapsuleopacificationfollowingphacoemulsificationinpatientswithuveitis
AT jaroudimahmoudo incidenceofposteriorcapsuleopacificationfollowingphacoemulsificationinpatientswithuveitis
AT tabbarakhalidf incidenceofposteriorcapsuleopacificationfollowingphacoemulsificationinpatientswithuveitis